Document Detail


Barriers to health care and protocol-based treatment of ectopic pregnancy.
MedLine Citation:
PMID:  15730166     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: To evaluate whether treatment provided for ectopic pregnancies was different for patients with identified barriers to health care, including ethnicity, lack of insurance, distance from the treating facility that provides services and undocumented residency, at an institution that utilizes a protocol-based algorithm for treatment of ectopic pregnancies. STUDY DESIGN: Charts of 401 patients who were diagnosed with ectopic pregnancy from January 1, 1993, through December 31, 1998, were reviewed to compare the use of medical treatment using methotrexate versus surgical treatment. Data were analyzed with respect to patient ethnicity, socioeconomic status (including insurance status and possession of a social security card [a proxy for legal residency status]), residence inside or outside the county of the treating facility, patient presentation and treatment outcomes. RESULTS: There was no difference in treatment modality or success of primary treatment for ectopic pregnancies between groups regardless of ethnicity, health care insurance, residence outside the county the treating facility was located in or possession of a social security number. CONCLUSION: The treatment of ectopic pregnancies at the University of New Mexico Health Sciences Center is consistent across ethnic and socioeconomic populations. A well-designed treatment protocol may help provide evidenced-based, consistent treatment for patients requiring care who also have identified barriers to medical and surgical treatment.
Authors:
Cindi Lewis; Carla Martinez; Rebecca Rogers
Related Documents :
9639186 - Ectopic pregnancy presenting with obturator nerve pain.
7782186 - Outcomes of ultrasound diagnosis of ectopic pregnancy. dependence on observer experience.
21056526 - Early experience with isobaric laparoendoscopic single-site surgery using a wound retra...
8886676 - Is maternal serum creatine kinase actually a marker for early diagnosis of ectopic preg...
24883336 - Model-based lamotrigine clearance changes during pregnancy: clinical implication.
8699366 - Pregnancy and immunosuppressive drug therapy.
Publication Detail:
Type:  Comparative Study; Journal Article    
Journal Detail:
Title:  The Journal of reproductive medicine     Volume:  50     ISSN:  0024-7758     ISO Abbreviation:  J Reprod Med     Publication Date:  2005 Jan 
Date Detail:
Created Date:  2005-02-25     Completed Date:  2005-05-19     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  0173343     Medline TA:  J Reprod Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  8-12     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, University of New Mexico Health Science Center, Albuquerque, NM 87131-001, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Abortifacient Agents, Nonsteroidal / therapeutic use
Clinical Protocols* / standards
Ethnic Groups / statistics & numerical data
Female
Health Services Accessibility*
Humans
Insurance, Health / utilization
Medically Uninsured
Methotrexate / therapeutic use
New Mexico
Pregnancy
Pregnancy, Ectopic / ethnology*,  therapy*
Retrospective Studies
Socioeconomic Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Abortifacient Agents, Nonsteroidal; 59-05-2/Methotrexate

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Retrospective histopathologic reevaluation of 18 cases of plasma cell vulvitis.
Next Document:  CIN in pregnancy: antepartum and postpartum cytology and histology.